Neuralink, the Elon Musk-backed brain-computer interface (BCI) company, has received FDA Breakthrough Device Designation for its technology aimed at restoring speech for individuals with severe
ElectroCore, a leader in non-invasive bioelectronic therapies, has completed the acquisition of NeuroMetrix and its Quell neuromodulation platform. The move is expected to enhance ElectroCore’s
Smith+Nephew is kicking off a months-long roadshow, “Cori on Tour,” across Central Europe to showcase its Cori surgical robot. The tour begins today in Berlin,
Dexcom and Oura have expanded their partnership to integrate Dexcom’s Stelo glucose biosensor with the Oura Ring app, offering real-time glucose insights to U.S. users.
Route 92 Medical has reached a settlement with Q’Apel Medical over an intellectual property dispute involving delivery catheter technology. The resolution includes the permanent removal
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
